As countries around the world seek to safely reopen businesses, schools, and other facets of society, mask use in the community to prevent the spread of SARS-CoV-2, in conjunction with other low-cost, low-tech, commonsense public health practices, is and will remain critical. More
False negatives are not the only troublesome outcome of a faulty coronavirus test. More
Mary Jo Copeland, on choosing decency over anxiety and fear. More
Women held in a South Georgia immigration detention center were referred to a gynecologist for problems unrelated to their reproductive health and were pressured to undergo unnecessary surgeries, according to a group of medical experts reviewing their complaints. More
A WBUR analysis found that more diverse nursing homes in Massachusetts had higher COVID-19 death rates than predominantly white facilities. More
As a psychiatrist, I should be well-equipped to deal with the emotions that arise in me when police shoot a Black person. But I'm not. More
Despite larger health threats consuming the nation this year, pharma did not let up on their fear-mongering advertisements. Check out a few of the scariest-- if you dare! More
The future of Covid-19 treatment is cloudier after the FDA approved Gilead Sciences Inc.'s remdesivir, the first virus treatment to get full authorization in the U.S. More
Gilead said it spent $1 billion to develop remdesivir. The NIH invested as much as $6.5 billion in it between 2000 and 2019. More
In August, the last inpatients were discharged. Next week, moving trucks are expected to haul off boxloads of patient files and medical records. More
The findings, published in BMJ, could re-energize the debate over whether blood plasma is an effective treatment for the disease. More
How does structural racism manifest in the hospital sector and what can we do about it? At the first in the Lown Presents event series, Lown Institute leaders invited a health equity expert and the CEO of one of the most inclusive hospitals in the nation to discuss this crucial topic. More
Communities of color are suffering disproportionately from coronavirus. The social determinants of health that lead to higher concentrations of hypertension and diabetes can be mitigated by investment in primary care. More
Have acres of industrial buildup around a Motor City neighborhood left residents especially vulnerable? More
When a Latina woman went to a Bay Area hospital, a doctor was dismissive of her COVID symptoms. Is unconscious bias one reason people of color are disproportionately affected by the coronavirus? More
A recent study by Megan B. Cole, PhD, MPH, and Kevin H. Nguyen, MS, takes a broader look at the extent of unmet social needs in low-income US adults and the relationship to health care access and quality. More
Americans living in "Cancer Alley" suffer from high rates of cancer. In this six-part series, USA TODAY investigates how racism fuels COVID-19 deaths. More
There are more than 50 million caregivers in the United States, from in-home providers to family volunteers. For these essential workers, the pandemic has represented a crisis on a different scale. More
The complex business structures of some private equity-backed dermatology groups allowed them to receive millions in COVID-19 funds. More
The University of Virginia promised reforms but has stopped short of announcing them, while hospital giant VCU Health has freed tens of thousands from property liens. More